Integer (NYSE:ITGR) Reaches New 12-Month High at $119.51

Integer Holdings Co. (NYSE:ITGR) reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $119.51 and last traded at $119.48, with a volume of 33983 shares. The stock had previously closed at $115.77.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and increased their target price for the stock from $105.00 to $135.00 in a research note on Monday. KeyCorp increased their price target on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Benchmark increased their price target on shares of Integer from $105.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, March 28th. Finally, CL King assumed coverage on shares of Integer in a report on Thursday, March 14th. They issued a “buy” rating and a $137.00 price target on the stock. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $120.50.

Integer Stock Up 0.6 %

The company has a current ratio of 2.80, a quick ratio of 1.71 and a debt-to-equity ratio of 0.64. The stock’s fifty day moving average price is $111.09 and its 200 day moving average price is $97.94. The stock has a market cap of $4.00 billion, a P/E ratio of 44.35, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10.

Integer (NYSE:ITGR) last released its earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 EPS for the quarter, beating the consensus estimate of $1.34 by $0.05. Integer had a net margin of 5.68% and a return on equity of 10.80%. The company had revenue of $413.15 million for the quarter, compared to analyst estimates of $409.04 million. During the same quarter last year, the firm earned $1.11 EPS. The firm’s quarterly revenue was up 10.9% compared to the same quarter last year. As a group, research analysts forecast that Integer Holdings Co. will post 5.28 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Integer

Several institutional investors have recently added to or reduced their stakes in ITGR. Congress Asset Management Co. MA lifted its position in shares of Integer by 7.5% in the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock worth $52,886,000 after purchasing an additional 31,736 shares during the period. Canandaigua National Bank & Trust Co. purchased a new position in Integer during the 1st quarter valued at about $233,000. HighPoint Advisor Group LLC purchased a new position in Integer during the 4th quarter valued at about $221,000. Quadrature Capital Ltd purchased a new position in Integer during the 4th quarter valued at about $378,000. Finally, Price T Rowe Associates Inc. MD lifted its position in Integer by 9.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 17,812 shares of the medical equipment provider’s stock valued at $1,765,000 after acquiring an additional 1,603 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.